Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion type Assertion NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_head.
- NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion wasGeneratedBy ECO_0000203 NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_provenance.
- NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion wasDerivedFrom befree-20150227 NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_provenance.
- NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion SIO_000772 21229279 NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_provenance.
- NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion evidence source_evidence_literature NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_provenance.
- NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_assertion description "[Concentrations of TNF-α (median 15.0 vs. 25.1 pg/ml, area under the receiver operating characteristic curve [AUC] 0.91), IL-8 (48.7 vs. 103.3 pg/ml, AUC 0.85), IP-10 (176 vs. 566 pg/ml, AUC 0.83), MCP-1 (449 vs. 735 pg/ml, AUC 0.78), suPAR (3.5 vs. 5.2 ng/ml, AUC 0.78), MIG (100 vs. 152 pg/ml, AUC 0.75), and HGF (3.69 vs. 5.58 ng/ml, AUC 0.71) were significantly higher in patients with cirrhosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502192.RAWBuXdrMHp6EkLgs3-0KJ8BMqxtLr8rq8wKHTM4PQ8bw130_provenance.